Who is sponsoring NCT03213015?

NCT03213015 is sponsored by Filipe Abdalla dos Reis.

What drugs are being tested in NCT03213015?

Interventions in NCT03213015: Ankle dorsiflexion measurement.

What condition does NCT03213015 study?

NCT03213015 studies Patellofemoral Pain Syndrome.

Is NCT03213015 still recruiting?

NCT03213015 is currently completed. Last updated 13 July 2017.

Last reviewed 2017-07-13 · How we verify

NCT03213015

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Correlation Between the Amplitude of Ankle Dorsiflexion and Occurrence of Patellofemoral Pain Syndrome

Completed NA Last updated 13 July 2017

What this trial tests

NA trial testing Ankle dorsiflexion measurement in Patellofemoral Pain Syndrome in 67 participants. Completed in 30 June 2017.

Timeline

25 January 2017

Primary endpoint
25 March 2017

30 June 2017

Quick facts

Lead sponsor	Filipe Abdalla dos Reis
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Design	sequential
Masking	none
Primary purpose	diagnostic
Enrollment	67
Start date	25 January 2017
Primary completion	25 March 2017
Estimated completion	30 June 2017
Sites	1 location across Brazil

Drugs / interventions tested

Ankle dorsiflexion measurement

Conditions studied

Patellofemoral Pain Syndrome — all drugs for Patellofemoral Pain Syndrome →

Sponsor

Filipe Abdalla dos Reis

Who can join

Adults 18 to 55, female only, with Patellofemoral Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study was to verify the clinical reliability of ankle dorsiflexion range of motion (ADROM) measurement with weight bearing (WB) using an app on the smartphone (iHand) and to verify if there is correlation between the limitation of the ADROM and the PFP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Patellofemoral Pain Syndrome

Currently open trials in the same condition.

NCT07318987 — EFFECT OF SAPHENOUS NERVE RELEASE ON PATIENTS WITH PATELLOFEMORAL PAIN SYNDROME · NA · recruiting
NCT06913426 — Effects of Pelvic Tilt Exercises Along With Hip and Knee Focused Exercises on Patients With Patellofemoral Pain Syndrome · NA · active not recruiting
NCT06875804 — Compressive Myofascial Release of the Vastus Lateralis on Lateral Patellar Tracking in Patellofemoral Pain Syndrome · NA · recruiting
NCT06598618 — Comparison of IASTM and Muscle Energy Technique in Patellofemoral Pain Syndrome. · NA · recruiting
NCT06566950 — BFR Training on Muscle Morphology · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03213015 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Filipe Abdalla dos Reis
Last refreshed: 13 July 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03213015.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing